Johnson & Johnson agrees to pay about $117 million to settle vaginal mesh litigation

(Reuters) – U.S. state attorneys general said on Thursday that Johnson & Johnson (NYSE:) and its unit had agreed to pay nearly $117 million to settle litigation over deceptive marketing of the company’s transvaginal surgical mesh devices.

Ohio Attorney General Dave Yost said in a statement the state would receive $6.3 million as part of the settlement, which also includes payments to 40 other participating states and the District of Columbia.

Thousands of women have sued Johnson & Johnson alleging that they were injured by its pelvic mesh devices, which are used to treat bladder issues and pelvic organ prolapse, in which organs shift from their normal positions.

Johnson & Johnson did not immediately respond to Reuters request for comment.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.